Eric Lynam
Chief Tech/Sci/R&D Officer chez SIGN THERPAR
Profil
Eric Lynam is currently the Director of Clinical Affairs at Sigyn Therapeutics, Inc. He previously worked as the Director of Scientific & Medical Affairs at Pharmatech, Inc.
Postes actifs de Eric Lynam
| Sociétés | Poste | Début |
|---|---|---|
| SIGN THERPAR | Chief Tech/Sci/R&D Officer | 26/01/2021 |
Anciens postes connus de Eric Lynam
| Sociétés | Poste | Fin |
|---|---|---|
Pharmatech, Inc.
 Pharmatech, Inc. Hospital/Nursing ManagementHealth Services Pharmatech, Inc. operates as an oncology specialized research management organization. It also offers provides diagnostics and anatomic pathology services. The company was founded by Matthew Wiener in 1987 and is headquartered in Denver, CO. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SIGN THERPAR | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pharmatech, Inc.
Pharmatech, Inc. Hospital/Nursing ManagementHealth Services Pharmatech, Inc. operates as an oncology specialized research management organization. It also offers provides diagnostics and anatomic pathology services. The company was founded by Matthew Wiener in 1987 and is headquartered in Denver, CO. | Health Services |
